Abstract
Glenohumeral arthritis in young patients is a challenging clinical problem without a gold standard for either nonoperative or operative treatment. These patients often have high activity levels and high expectations, are employed, and have a long life expectancy. There are few studies that specifically examine treatment outcomes in young patients. While many treatment options can yield short-term success, eventual failures at mid-term and long-term follow-up are expected. Because of these factors, treatment decisions are particularly complex.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
